Royce & Associates LP Landec Corp \Ca\ Transaction History

Royce & Associates LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$7.59 - $10.8 $2.28 Million - $3.24 Million	-300,318 Reduced 79.89%	75,610 $735,000
Q2 2020 Aug 07, 2020	BUY	$7.96 - $11.54 $293,724 - $425,825	36,900 Added 10.88%	375,928 $2.99 Million
Q1 2020 May 12, 2020	BUY	$7.69 - $11.68 $2.03 Million - $3.08 Million	263,418 Added 348.39%	339,028 $2.95 Million
Q4 2019 Feb 06, 2020	SELL	$9.09 - $11.89 $765,941 - $1 Million	-84,262 Reduced 52.71%	75,610 $855,000
Q3 2019 Nov 13, 2019	SELL	$9.66 - $12.36 $2.13 Million - $2.72 Million	-220,208 Reduced 57.94%	159,872 $1.74 Million
Q2 2019 Aug 12, 2019	SELL	$9.32 - $12.98 $4.93 Million - $6.86 Million	-528,798 Reduced 58.18%	380,080 $3.56 Million
Q1 2019 May 09, 2019	SELL	$10.35 - $13.06 $5.34 Million - $6.74 Million	-516,376 Reduced 36.23%	908,878 $11.2 Million
Q4 2018 Feb 11, 2019	BUY	$11.64 - $15.41 $366,543 - $485,260	31,490 Added 2.26%	1,425,254 $16.9 Million
Q3 2018 Nov 13, 2018	BUY	$12.65 - $15.15 $1.51 Million - $1.81 Million	119,356 Added 9.37%	1,393,764 $20.1 Million
Q2 2018 Aug 09, 2018	BUY	$13.05 - $15.45 $524,831 - $621,352	40,217 Added 3.26%	1,274,408 $19 Million
Q1 2018 May 14, 2018	BUY	$12.0 - $14.45 $222,000 - $267,325	18,500 Added 1.52%	1,234,191 $16.1 Million
Q4 2017 Feb 09, 2018	SELL	$11.65 - $13.35 $13,980 - $16,020	-1,200 Reduced 0.1%	1,215,691 $15.3 Million
Q3 2017 Nov 13, 2017	BUY	$11.95 - $13.35 $32,922 - $36,779	2,755 Added 0.23%	1,216,891 $15.8 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,214,136	1,214,136 $18 Million

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.